[
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Valuation After Mixed Q4 2025 Results And 2026 Growth Outlook",
    "summary": "Boston Scientific (BSX) is in focus after reporting Q4 2025 and full year results that combined higher sales and earnings with mixed signals in key growth areas and guidance for 2026. See our latest analysis for Boston Scientific. The share price has retreated sharply in recent months, with a 30 day share price return of 20.28% and a 90 day return of 27.23%. However, the 3 year total shareholder return of 60.57% and 5 year total shareholder return of 96.50% remain well above these short term...",
    "url": "https://finnhub.io/api/news?id=2589c2d2a0162aa0ccadb3aaaa1af07ffe2308a5a7574ae7931a41fad5b7e44b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771034933,
      "headline": "Boston Scientific (BSX) Valuation After Mixed Q4 2025 Results And 2026 Growth Outlook",
      "id": 139092662,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) is in focus after reporting Q4 2025 and full year results that combined higher sales and earnings with mixed signals in key growth areas and guidance for 2026. See our latest analysis for Boston Scientific. The share price has retreated sharply in recent months, with a 30 day share price return of 20.28% and a 90 day return of 27.23%. However, the 3 year total shareholder return of 60.57% and 5 year total shareholder return of 96.50% remain well above these short term...",
      "url": "https://finnhub.io/api/news?id=2589c2d2a0162aa0ccadb3aaaa1af07ffe2308a5a7574ae7931a41fad5b7e44b"
    }
  }
]